Skip to main content

Hemoglobin and types

Definition

Hemoglobin is a protein that carries oxygen in the blood. Hemoglobin electrophoresis measures the levels of the different types of this protein in the blood.
Alternative Names

Hb electrophoresis; Hgb electrophoresis; Electrophoresis - hemoglobin; Thallasemia - electrophoresis; Sickle cell - electrophoresis; Hemoglobinopathy - electrophoresis

How the Test is Performed

A blood sample is needed.
In the lab, the technician places the blood sample on special paper and applies an electric current. The hemoglobins move on the paper and form bands that show the amount of each type of hemoglobin.
How to Prepare for the Test

No special preparation is necessary for this test.

How the Test will Feel

When the needle is inserted to draw blood, some people feel moderate pain. Others feel only a prick or stinging sensation. Afterward, there may be some throbbing or a slight bruise. This soon goes away.
Why the Test is Performed

You may have this test if your health care provider suspects that you have a disorder caused by abnormal forms of hemoglobin (hemoglobinopathy).
Many different types of hemoglobin (Hb) exist. The most common ones are HbA, HbA2, HbE, HbF, HbS, HbC, HbH, and HbM. Healthy adults only have significant levels of only HbA and HbA2.
Some people may also have small amounts of HbF. This is the main type of hemoglobin in an unborn baby's body. Certain diseases are associated with high HbF levels (when HbF is more than 2% of the total hemoglobin).
HbS is an abnormal form of hemoglobin associated with sickle cell anemia. In people with this condition, the red blood cells sometimes have a crescent or sickle shape. These cells easily break down or can block small blood vessels.
HbC is an abnormal form of hemoglobin associated with hemolytic anemia. The symptoms are much milder than they are in sickle cell anemia.
Other, less common, abnormal Hb molecules cause other types of anemia.
Normal Results

In adults, these are normal percentages of different hemoglobin molecules:

HbA: 95% to 98% (0.95 to 0.98)

HbA2: 2% to 3% (0.02 to 0.03)

HbE: Absent

HbF: 0.8% to 2% (0.008 to 0.02) 

HbS: Absent

HbC: Absent

In infants and children, these are normal percentage of HbF molecules:

HbF (newborn): 50% to 80% (no0.5 to 0.8)

HbF (6 months): 8%

HbF (over 6 months): 1% to 2%
Normal value ranges may vary slightly among different laboratories. Some labs use different measurements or may test different samples. Talk to your provider about the meaning of your specific test results.

What Abnormal Results Mean

Significant levels of abnormal hemoglobins may indicate:

Hemoglobin C disease

Rare hemoglobinopathy

Sickle cell anemia

Inherited blood disorder in which the body makes an abnormal form of hemoglobin (thalassemia)

You may have false normal or abnormal results if you have had a blood transfusion within 12 weeks of this test.
Risks

There is very little risk involved with having your blood taken. Veins and arteries vary in size from one person to another and from one side of the body to the other. Taking blood from some people may be more difficult than from others.
Other risks associated with having blood drawn are slight but may include:
Excessive bleeding

Fainting or feeling lightheaded

Hematoma (blood buildup under the skin)

Infection (a slight risk any time the skin is broken)

Comments

Popular posts from this blog

deploying chemotherapy to hold the tumor cells

Engineers at Duke University have developed a novel delivery system for cancer treatment and demonstrated its potential against one of the disease’s most troublesome forms. In newly published research in mice with pancreatic cancer, the scientists showed how a radioactive implant could completely eliminate tumors in the majority of the rodents, demonstrating what they say is the most effective treatment ever studied in these pre-clinical models. Pancreatic cancer is notoriously difficult to diagnose and treat, with tumor cells of this type highly evasive and loaded with mutations that make them resistant to many drugs. It accounts for just 3.2 percent of all cancers, yet is the third leading cause of cancer-related death. One way of tackling it is by deploying chemotherapy to hold the tumor cells in a state that makes them vulnerable to radiation, and then hitting the tumor with a targeted radiation beam.